Canaccord Analyst Upgrades AngioDynamics, Raises PT To $20

Canaccord analyst Jason Mills today upgraded his rating on AngioDynamics Inc. (ANGO) to Buy from Hold, and raised his price target to $20 from $16.

Medtronic Upgraded To Outperform From Market Perform At William Blair

Analyst Ben Andrew of William Blair upgraded Medtronic, Inc. (MDT) from Market Perform to Outperform in a research report released on today.

Intel Corporation Upgraded to Buy From Neutral At Roth Capital

Analyst Krishna Shankar of Roth Capital upgraded Intel Corporation (INTC) from Neutral to Buy, and boosted his price target on INTC from $28.00 to $35.

Canaccord Downgrades B/E Aerospace to Hold As Company Sale Looks Incrementally Less Likely

In a research report issued today, B/E Aerospace Inc. (BEAV) was downgraded by analyst Kenneth Herbert at Canaccord from a “buy” rating to a “hold” rating.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts